LIXT
NOMAD POWER SOLUTIONS, INC.Price
Daily candles with volume.
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- Short sellersBUILDING
Short interest +84.0% to 709.8K shares. 1.4 days to cover, ≈4.7% of shares.
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Jul 1, 2026 | Felix Lourdes Director | AWARD | 30,000 sh |
| Jul 1, 2026 | Stazzone Peter Chief Financial Officer | AWARD | 50,000 sh |
| Jul 1, 2026 | Primus Guy Warren Director | AWARD | 15,000 sh |
| Jul 1, 2026 | Pursglove Geordan Garrett CEO and Chairman of the Board | AWARD | 350,000 sh |
| Jul 1, 2026 | Sawyer Jason David Director | AWARD | 40,000 sh |
| Jul 1, 2026 | Holloway Michael Andrew Director | AWARD | 15,000 sh |
| May 29, 2026 | Porter Stuart D Director | AWARD | 25,000 sh |
| Apr 15, 2026 | Holloway Michael Andrew Director | AWARD | 25,000 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
Short side
FINRA· Jun 30, 2026SecBot reports
9 filings · 1 press release · 3 bullish · 2 bearish · 4 neutral- NEUTRAL 8-KJul 2, 2026
{ "summary": "LIXTE Biotechnology completed its transformative reverse merger with NOMAD…
LLM returned non-JSON response. Review the filing manually.
- BULLISH 8-KJun 18, 2026
LIXTE Biotechnology issued a $6.5 million secured promissory note to NOMAD Transportable Power…
The pre-closing loan signals strong conviction in the NOMAD acquisition and provides NOMAD with capital to execute on its order backlog. Traders should watch for merger closing around July 1, 2026 —…
- BULLISH 8-KJun 16, 2026
LIXTE Biotechnology Holdings (LIXT) entered into a definitive merger agreement to acquire 100% of…
Monitor closing conditions, particularly the $16.5M cash condition (likely satisfied by the June 4 offering) and Nasdaq listing approval for the Exchange Common Shares. Post-closing, the key…
- BULLISH PRESS RELEASEJun 12, 2026
LIXTE Biotechnology (LIXT) announced a definitive agreement to acquire 100% of NOMAD Transportable…
This transformative acquisition pivots LIXT from a clinical-stage biotech with no approved products to a high-growth energy infrastructure company. The structural permitting advantage and strong…
All LIXT filing & press-release reports (10)
- 8-K reportJul 2, 2026
- 8-K reportJun 18, 2026
- 8-K reportJun 16, 2026
- PRESS-RELEASE reportJun 12, 2026
- 8-K reportJun 4, 2026
- 424B5 reportJun 4, 2026
- 8-K reportJun 1, 2026
- PRESS-RELEASE reportMay 14, 2026
- 8-K reportApr 17, 2026
- PRESS-RELEASE reportApr 13, 2026